iRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026
iRhythm Holdings (IRTC) will release its third-quarter 2026 financial results after trading closes on November 5, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
iRhythm Holdings (IRTC) will release its third-quarter 2026 financial results after trading closes on November 5, 2026.
Management will host a corresponding conference call at 1:30 p.m. PT / 4:30 p.m. ET. A live and archived webcast will be available in the Quarterly Results section at investors.irhythmtech.com.
Details
News Market Reaction – IRTC
On Oct 16, the first trading day after this news, IRTC closed 0.65% below the previous close.
Data tracked by StockTitan Argus for the Oct 16 session.
Key Figures
- Results release date
- November 5, 2026
- Third-quarter 2026 financial results, after the close
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will release financial results for the third quarter 2026 after the close of trading on Thursday, November 5, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
Interested parties may access a live and archived webcast of the conference call on the “Quarterly Results” section of the company’s investor website at investors.irhythmtech.com.
About iRhythm Holdings, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.
Investor Contact
Francis Pruell
investors@irhythmtech.com
Media Contact
Kassandra Perry
mediarelations@irhythmtech.com
